The use of GLP-1 agonists compared with bupropion-naltrexone was associated with increased risk of pancreatitis, bowel obstruction, and gastroparesis (a condition that slows or prevents the stomach from emptying its contents into the small intestine), but not biliary disease.8 Nutraceutical Compensation There are some nutraceuticals which may help compensate for some of the adverse effects associated with the use of GLP-1 agonist drugs
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebocontrolled, parallel-group study
However, the market remained relatively small until semaglutide, initially approved for type 2 diabetes under the brand name Ozempic, gained widespread attention for its significant weight loss effects
Ipamorelin is a pentapeptide, made of five amino acids arranged in a specific way to make it active
L-Glutathione Power provides glutathione directly, while NAC is a precursor that supports endogenous glutathione synthesis